Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Widefield swept-source OCT angiography biomarkers associated with the development of cardiovascular disease and all-cause mortality in patients with diabetic retinopathy: A prospective study
Author Affiliations & Notes
  • Edward S Lu
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Krystal K Phu
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Ying Cui
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Ophthalmology, Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
  • Xinyi Ding
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Rongrong Le
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Wenzhou Medical University Eye Hospital, Wenzhou, Zhejiang, China
  • Itika Garg
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Grace Baldwin
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Matthew Finn
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Peyman Razavi
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Ines Lains
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • David M Wu
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Deeba Husain
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Leo A Kim
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Nimesh Arvind Patel
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Demetrios G. Vavvas
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • John B Miller
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Edward Lu None; Krystal Phu None; Ying Cui None; Xinyi Ding None; Rongrong Le None; Itika Garg None; Grace Baldwin None; Matthew Finn None; Peyman Razavi None; Ines Lains None; David Wu Massachusetts Eye and Ear, Code P (Patent); Deeba Husain Genentech, Allergan, Novartis, Omeicos Therapeutics, Code C (Consultant/Contractor), National Eye Institute, Code F (Financial Support); Leo Kim 11229662, WO2019099595, Code P (Patent); Nimesh Patel Alimera Sciences, Alcon, Allergan, Genentech, Eyepoint, Lifesciences Guidepoint, GLG, Code C (Consultant/Contractor), Retina Innovation Fund, Code F (Financial Support); Demetrios Vavvas Olix Pharma, Valitor, TwentyTwenty, Sumitomo/Sunovion, Cambridge Polymer Group, Code C (Consultant/Contractor), Drusolv Therapeutics, Code O (Owner), Massachusetts Eye and Ear, Code P (Patent); John Miller Alcon, Allergan, Carl Zeiss, Sunovion, Genentech, Topcon, Code C (Consultant/Contractor)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4871. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Edward S Lu, Krystal K Phu, Ying Cui, Xinyi Ding, Rongrong Le, Itika Garg, Grace Baldwin, Matthew Finn, Peyman Razavi, Ines Lains, David M Wu, Deeba Husain, Leo A Kim, Nimesh Arvind Patel, Demetrios G. Vavvas, John B Miller; Widefield swept-source OCT angiography biomarkers associated with the development of cardiovascular disease and all-cause mortality in patients with diabetic retinopathy: A prospective study. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4871.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To explore the association among widefield swept-source optical coherence tomography angiography (WF SS-OCTA) metrics and systemic parameters and the development of myocardial infarction (MI), congestive heart failure (CHF), and all-cause mortality in patients with diabetic retinopathy (DR).

Methods : This prospective, observational, single-institution study included 178 eyes from 119 adults with NPDR and PDR, followed for at least 3 months. All patients were imaged with WF SS-OCTA (6×6mm, Montage 15×15mm and HD-51 Line scan). Images were independently evaluated by two graders for quantitative and qualitative WF SS-OCTA metrics defined a priori. WF SS-OCTA metrics, systemic, and ocular parameters were screened using Least Absolute Shrinkage and Selection Operator (LASSO) variable selection. Multilevel mixed-effects Cox regression models were used to identify parameters associated with the occurrence of MI, CHF, and all-cause mortality, adjusting for age and sex.

Results : Over a median follow-up of 44 months (range: 3-57 months), 11 patients (9.2%) had a cardiovascular event (MI or CHF) and 7 patients died (5.9%). WF SS-OCTA neovascularization vessel density (HR=155, 95%CI:6.8-3,536, P=0.002) and vitreous hemorrhage (HR=81.7, 95%CI:9.1-736, P<0.001) were associated with the development of CHF (9 events). Regarding cardiovascular disease (CHF and MI, 16 events), vitreous hemorrhage (HR=22.5, 95%CI:6.1-82.6, P<0.001) and prior treatment with anti-VEGF injections or panretinal photocoagulation (HR=14.4, 95%CI:3.9-52.9, P<0.001) were associated with increased risk. Macular perfusion in the deep capillary plexus on WF SS-OCTA (HR=1.4, 95%CI:1.1-1.7, P=0.003) and prior treatment (anti-VEGF, PRP, focal laser, or pars plana vitrectomy) (HR=19.0, 95%CI:2.9-124.7, P=0.002) were associated with all-cause mortality.

Conclusions : Neovascularization and macular perfusion metrics on WF SS-OCTA were associated with the development of cardiovascular disease and all-cause mortality in patients with DR. Larger samples and longer follow-up are needed to verify these imaging metrics as potential predictors of cardiovascular events and mortality.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×